Jm. Li et al., THE EXPRESSION OF HUMAN ENDOGENOUS RETROVIRUS-3 IN FETAL CARDIAC TISSUE AND ANTIBODIES IN CONGENITAL HEART-BLOCK, Clinical and experimental immunology, 104(3), 1996, pp. 388-393
Endogenous retrovirus-3 (ERV-3) is an endogenous retrovirus encoding a
n open reading frame for an envelope protein expressed in placenta. In
this study we also found high levels of expression in fetal heart, wi
th peak expression occurring between 11 and 17 weeks of gestation. Ant
ibodies to a peptide corresponding to a predicted epitope of ERV-3 wer
e studied by ELISA in sera from 32 healthy women, 47 women during preg
nancy. 19 post-partum, 34 with Sjogren's syndrome (SS), 28 with system
ic lupus erythematosus (SLE) and 48 mothers of babies with congenital
heart block (CHB). Elevated levels of antibodies to ERV-3 were found i
n normal pregnancy and in patients with SS or SLE. Compared with norma
l sera the highest levels occurred in mothers of CHB babies (P<0.001).
Antibodies from sera from three CHB mothers bound to recombinant tran
smembrane protein of ERV-3 on immunoblots, and to sections of fetal ca
rdiac tissue and placenta. This study has shown evidence of autoimmuni
zation to ERV-3 during pregnancy, with particularly high levels of ant
ibodies in mothers of CHB babies. The expression of ERV-3 in fetal hea
rt and the presence of antibodies in maternal sera suggest a possible
role in the pathogenesis of CHB.